Concepedia

D.R. Camidge

DC

1

Publications

21

Citations

1

H-Index

2025

Active since

Affiliations

University of Colorado Cancer Center(Current)

D.R. Camidge is an author at University of Colorado Cancer Center.

Publications per year

2025–2025

1

Publications

1

Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib

H. Horinouchi, B.C. Cho, D.R. Camidge et al. · Annals of Oncology · 2025 · 21 citations · Full text

Rows per page

1–1 of 1